Navigation Links
STEM CELLS Journal Names Co-Editors

DURHAM, N.C., Nov. 15 /PRNewswire/ -- AlphaMed Press, publisher of the journal STEM CELLS(R), has named Donald G. Phinney and Miodrag Stojkovic as co-editors.

Curt I. Civin, current STEM CELLS Editor, retires after eight years of unprecedented growth in areas of the journal's most significant metrics: Impact Factor, number of pages published, and number of manuscripts submitted. During his tenure as editor-in-chief, Dr. Civin was assisted by three outgoing senior editors: Alan M. Gewirtz, Robert G. Hawley, and Margaret A. Goodell.

Martin J. Murphy, STEM CELLS' Executive Editor, expressed his appreciation to the retiring editors. "I am deeply appreciative for the cumulative 26 years of leadership that Drs. Civin, Gewirtz, Hawley and Goodell have unstintingly devoted to STEM CELLS," he said. "We are honored by the care that they devoted to the review process, a process that has been enhanced by an order of magnitude under their inspiring leadership."

In the last six years, STEM CELLS' Impact Factor has risen from 2.689 to 7.924, and the number of pages published has doubled in the last two years alone, as has the number of manuscripts submitted.

The new editors, Phinney and Stojkovic, are not new to STEM CELLS. For the past year they have served as Associate Editors with responsibility to oversee the peer review of all manuscripts. They will be supported by a team of new associate editors.

Donald G. Phinney, PhD, is Professor of Immunology and Microbiology and Associate Director for Research at Tulane's Center for Gene Therapy. Professor Phinney investigates the basic biology of mesenchymal stem cells and their potential use for treatment of chronic lung disease and disorders of the central nervous system. Studies in mice have spurred pre-clinical trials to evaluate the safety and efficacy of intracranial stem cell transplantation for the treatment of neurological sequelae resulting from lysosomal storage diseases.

Miodrag Stojkovic, PhD, is Deputy Director of Centro de Investigacion Principe Felipe and head of its Cellular Reprogramming Laboratory, Valencia, Spain. In September 2006, a team led by Professor Stojkovic announced derivation of pluripotent human embryonic stem cells (hESC) from non-viable early human embryos that had stopped their cleavage. Using surplus and donated embryos, the scientists demonstrated that these arrested embryos could be used under suitable laboratory conditions for derivation of hESC. Published in STEM CELLS, the technique may help to understand and fight debilitating diseases.


STEM CELLS(R), the international journal of cell differentiation and proliferation, publishes original articles at the leading edge of stem cell research and regenerative medicine. Beginning its 26th year of publication in 2008, STEM CELLS(R) is the first journal devoted to this fast-paced field of research. Its Impact Factor, the highest of all journals devoted to the peer reviewed publication of stem cells literature, is 7.924. For more information, please visit or contact:

George Kendall

Director of Operations and Business Development

AlphaMed Press

318 Blackwell Street, Suite 260

Durham, NC 27701


Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
2. Reovirus Infection of Melanoma Cells Generates Anti-Tumour Immunity
3. Scientists synthesize memory in yeast cells
4. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
5. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
6. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
7. Scientists synthesize memory in yeast cells
8. Breakthrough research identifies how cells from pigs may cure diabetes
9. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
10. Tips from the Journals of the American Society for Microbiology
11. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
Post Your Comments:
(Date:12/1/2015)...  CardioCell LLC, a Stemedica Cell Technologies Inc. ... indications, intends to proceed with finalizing a Phase ... a Heart Failure Advisory Board comprising cardiology key ... members . In a recent meeting members of ... efficacy data from CardioCell,s on-going chronic heart failure ...
(Date:12/1/2015)... Frederick, MD (PRWEB) , ... December 01, 2015 ... ... management solutions provider, announces that its best selling system laboratory animal colony management ... ezColony® Cloud today, without investing in on-site IT resources., , ...
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  Symic, ... and affect the extracellular matrix (ECM), today announced that ... financing to advance the company,s pipeline, including its lead ... Lilly Ventures and includes the participation by all existing ... new funding brings the total capital raised by Symic ...
(Date:12/1/2015)... , December 1, 2015 Dr. Harry Lander , President ... serving as Chief Science Officer and recruits five ... Harry Lander , President of Regen, expands his role to ... recruits five distinguished scientists to join advisory team ... expands his role to include serving as ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):